SCHEMBL30422164

SCHEMBL30422164

O=C(O)c1cccc(N2CCNC2=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
HPGD P15428 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
KMT2A Q03164 8/20 0.55
MEN1 O00255 7/20 0.55
GAA P10253 3/20 0.55
KDM4E B2RXH2 3/20 0.55
HSD17B10 Q99714 2/20 0.55
L3MBTL1 Q9Y468 4/20 0.51
KMO O15229 1/20 0.51
MAPT P10636 2/20 0.49
HCRTR1 O43613 1/20 0.48
POLB P06746 3/20 0.47
RECQL P46063 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
USP2 O75604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12169427 1.00 ALDH1A1 (0.61) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL2883293 0.86 ALOX5 (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL132460 0.82 GAA (0.55) ALDH1A1HPGDCYP1A2CYP2D6CYP2C19
SCHEMBL10022670 0.80 ALDH1A1 (0.57) ALDH1A1HPGDKMT2AMEN1KDM4E
SCHEMBL29607387 0.79 DDB1 (0.64) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL21409360 0.79 DDB1 (0.64) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL2878333 0.78 ITGB3 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL27945523 0.78 HTR1A (0.54) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL146714 0.77 NPC1 (0.56) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7344849 0.77 ALOX5 (0.59) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966226-B1 MASP INHIBITORY COMPOUNDS AND USES THEREOF BAYER AG (DE) 2025-12-24 EP disclosed
US-12503491-B2 MASP inhibitory compounds and uses thereof BAYER AKTIENGESELLSCHAFT (DE) 2025-12-23 US disclosed
US-20240124522-A1 MASP INHIBITORY COMPOUNDS AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2024-04-18 US disclosed
US-11667675-B2 MASP inhibitory compounds and uses thereof BAYER AKTIENGESELLSCHAFT (DE) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503491-B2 MASP inhibitory compounds and uses thereof MASP2, SERPINB1, SPINT2 ALDH1A1 2138/4885HPGD 2199/4885CYP1A2 4511/4885
US-11667675-B2 MASP inhibitory compounds and uses thereof MASP2, SERPINB1, SPINT2 ALDH1A1 2138/4885HPGD 2199/4885CYP1A2 4511/4885
US-20240124522-A1 MASP INHIBITORY COMPOUNDS AND USES THEREOF MASP2, SERPINB1, SPINT2 ALDH1A1 2138/4885HPGD 2199/4885CYP1A2 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.